Back to Results
First PageMeta Content
Carbamates / Organofluorides / Fixed dose combination / Lopinavir/ritonavir / Bristol-Myers Squibb / Antiretroviral drug / Lopinavir / Reverse-transcriptase inhibitor / Efavirenz / Chemistry / Organic chemistry / Protease inhibitors


Lopinavir/ritonavir (ABT-378) M03-613 Clinical Study Report R&D[removed]
Add to Reading List

Document Date: 2014-12-18 17:16:43

Open Document

File Size: 69,09 KB

Share Result on Facebook

City

Ritonavir / /

Company

Cox / Abbott Laboratories / ITT / /

Continent

Europe / /

Country

France / United States / Canada / United Kingdom / Spain / /

Event

FDA Phase / Product Recall / Product Issues / /

IndustryTerm

treatment of HIV / food / /

MedicalCondition

very high cholesterol / lymphoma / coma / hemorrhoids / detectable low-level viremia / hepatitis C / low level viremia / pancreatitis / angina / diarrhea / hyperlipemia / rash / abnormal dreams / infection / hepatitis / cardiac arrest / dizziness / renal failure / rectal disorder / baseline disease / /

MedicalTreatment

antiretroviral therapy / HAART / /

Person

Lot Numbers / /

Position

investigator / using Fisher / Antiretroviral-Naïve HIV-Infected Subjects Coordinating Investigator / /

Product

Combivir / efavirenz / zidovudine / lamivudine / NRTIs / M03-613 / /

ProvinceOrState

Michigan / /

Technology

genotype / /

SocialTag